Mastocytes et inflammation
暂无分享,去创建一个
[1] P. Vermersch,et al. Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study , 2012, BMC Neurology.
[2] S. Sultan,et al. Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy , 2011, PloS one.
[3] J. Butterfield,et al. Neurologic symptoms and diagnosis in adults with mast cell disease , 2011, Clinical Neurology and Neurosurgery.
[4] L. Hugonot-Diener,et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial , 2011, Alzheimer's Research & Therapy.
[5] R. Toes,et al. Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role for mast cells and basophils? , 2011, Annals of the rheumatic diseases.
[6] P. Dubreuil,et al. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study , 2010, American journal of hematology.
[7] H. Sokol,et al. Gastrointestinal involvement and manifestations in systemic mastocytosis , 2010, Inflammatory bowel diseases.
[8] S. Abraham,et al. Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.
[9] Ashley M. Miller,et al. Mast cells express IL-17A in rheumatoid arthritis synovium. , 2010, Journal of immunology.
[10] T. Moon,et al. Advances in mast cell biology: new understanding of heterogeneity and function , 2010, Mucosal Immunology.
[11] W. Sippl,et al. Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT , 2009, PloS one.
[12] M. Colombo,et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. , 2009, Blood.
[13] A Magnan,et al. Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics , 2009, Allergy.
[14] X. Mariette,et al. Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study , 2009, Arthritis research & therapy.
[15] J. Crish,et al. Mast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes1 , 2009, The Journal of Immunology.
[16] M. Colombo,et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. , 2008, Immunity.
[17] Melissa A Brown,et al. Mast Cells , 2008, Annals of the New York Academy of Sciences.
[18] O. Hermine,et al. Mastocytosis is not related to allergic diseases , 2008, Allergy.
[19] D. Metcalfe. Mast cells and mastocytosis. , 2008, Blood.
[20] T. Lane,et al. The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease , 2008, The Journal of experimental medicine.
[21] W. Ferrell,et al. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. , 2007, Arthritis and rheumatism.
[22] David C. Gondek,et al. Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.
[23] M. Tsai,et al. Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.
[24] J. Marshall,et al. Mast cells in innate immunity. , 2004, The Journal of allergy and clinical immunology.
[25] Y. Kitamura,et al. What is the physiological function of mast cells? , 2003, Experimental dermatology.
[26] C. Benoist,et al. Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis , 2002, Science.
[27] C. Gutekunst,et al. Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.
[28] S. Hauser,et al. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients , 1995, Annals of neurology.
[29] David A. Williams,et al. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.
[30] M. E. Walker,et al. New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? , 2012, Biochimica et biophysica acta.